Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2013 - 2026)

Angiodynamics' Non-Current Deferred Tax Liability history runs 14 years deep, the most recent figure standing at $5.3 million for Q2 2026.

• Quarterly Non-Current Deferred Tax Liability rose 30.52% year-over-year to $5.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.3 million (up 30.52% YoY) and the FY2026 annual result came in at $5.3 million, up 30.52% from the prior year.
• Non-Current Deferred Tax Liability was $5.3 million for Q2 2026 at Angiodynamics, up from $4.6 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $17.8 million in Q4 2023 and bottomed at $1.3 million in Q3 2023.
• A 5-year average of $8.6 million and a median of $5.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability plunged 91.54% — and 2024, when it surged 261.69%.
• Angiodynamics' Non-Current Deferred Tax Liability stood at $14.3 million in 2022, then increased by 24.27% to $17.8 million in 2023, then plunged by 75.59% to $4.3 million in 2024, then slipped by 0.07% to $4.3 million in 2025, then advanced by 22.74% to $5.3 million in 2026.
• Business Quant data shows ANGO's Non-Current Deferred Tax Liability at $5.3 million in Q2 2026, $4.6 million in Q1 2026, and $4.3 million in Q4 2025.